Linagliptin is an oral medication used to manage type 2 diabetes mellitus. It belongs to the class of DPP-4 inhibitors, which work by increasing insulin secretion and decreasing glucagon levels in response to meals. This helps lower blood glucose levels effectively. Linagliptin is often prescribed alongside diet and exercise to improve glycemic control. Side effects may include upper respiratory infections and headache. In summary, Linagliptin is a valuable option for managing type 2 diabetes.
Linagliptin inhibits the enzyme DPP-4, leading to increased levels of incretin hormones, which promote insulin secretion and inhibit glucagon release, thereby lowering blood glucose levels.
No published brands for this salt yet.